Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.10.0.1
Stock-Based Compensation
9 Months Ended
Sep. 30, 2018
Stock-Based Compensation [Abstract]  
STOCK-BASED COMPENSATION

12. STOCK-BASED COMPENSATION

 

Restricted Stock

 

The following table summarizes the Company’s restricted stock activity during the nine months ended September 30, 2018:

 

          Weighted Average  
    Number of     Grant Date  
    Shares     Fair Value  
Outstanding at January 1, 2018     16,858     $ 169.00  
Granted     -       -  
Vested     -       -  
Forfeited/Cancelled     -       -  
Exercised     -       -  
Outstanding at March 31, 2018     16,858     $ 169.00  
                 
Granted     -       -  
Vested     -       -  
Forfeited/Cancelled     (6,915 )     178.31  
Exercised     -       -  
Outstanding at June 30, 2018     9,943     $ 162.52  
                 
Granted     -       -  
Vested     -       -  
Forfeited/Cancelled     -       -  
Exercised     -       -  
Outstanding at September 30, 2018     9,943     $ 162.52  

 

For the three months ended September 30, 2018 and 2017, and the nine months ended September 30, 2018, the Company did not incur stock compensation expense from the issuance of common stock to employees and consultants. For the nine months ended September 30, 2017, the Company incurred $13 in stock compensation expense from the issuance of common stock to employees and consultants.

 

The Company recorded an additional $4 and $104 in stock compensation expense on shares subject to vesting terms in previous periods during the three months ended September 30, 2018 and 2017, respectively. The Company recorded an additional $107 and $1,081 in stock compensation expense on shares subject to vesting terms in previous periods during the nine months ended September 30, 2018 and 2017, respectively. 

 

Warrants 

 

For the three and nine months ended September 30, 2017, the Company incurred stock compensation expense of $747 from the issuance of warrants to employees and consultants. 

 

Options 

 

There were no options granted during the nine months ended September 30, 2018 or 2017. 

 

The following table summarizes the Company’s stock option activity and related information for the nine months ended September 30, 2018: 

 

          Weighted Average        
    Shares Underlying Options     Exercise Price     Remaining Contractual Term (in years)     Aggregate Intrinsic Value (in thousands)  
Outstanding at January 1, 2018   417     $ 1,488.00     4.29     $           -  
Granted     -       -       -       -  
Forfeited and expired     -       -       -       -  
Exercised     -       -       -       -  
Outstanding at September 30, 2018     417     $ 1,488.00       3.54     $ -  
Exercisable at September 30, 2018     417     $ 1,488.00       3.54     $ -  

 

The aggregate intrinsic value for outstanding options is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock as of September 30, 2018 and December 31, 2017 of $0.003 and $0.27, respectively.